Disc Medicine Inc
NASDAQ:IRON
Disc Medicine Inc
NASDAQ:IRON
Price:
69.45
USD
-1.04%
Market Closed
Market Cap:
$2.7B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Disc Medicine Inc
NASDAQ:IRON
|
US |
|
H
|
Hanall Biopharma Co Ltd
KRX:009420
|
KR |
|
Goldman Sachs BDC Inc
NYSE:GSBD
|
US |
|
C
|
Century Ginwa Retail Holdings Ltd
HKEX:162
|
HK |
|
A
|
American Salars Lithium Inc
OTC:ASALF
|
CA |
|
Nova Cannabis Inc
TSX:NOVC
|
CA |
|
Geox SpA
MIL:GEO
|
IT |
|
F
|
Fuji Seal International Inc
TSE:7864
|
JP |
Balance Sheet
Balance Sheet Decomposition
Disc Medicine Inc
Disc Medicine Inc
Balance Sheet Decomposition is not available for
Disc Medicine Inc
Disc Medicine Inc
Balance Sheet
Disc Medicine Inc
Disc Medicine Inc
Currency: USD
| Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|
| Assets | ||||||
| Cash & Cash Equivalents |
1
|
137
|
195
|
360
|
0
|
|
| Cash |
1
|
0
|
0
|
0
|
0
|
|
| Cash Equivalents |
0
|
137
|
195
|
360
|
0
|
|
| Other Current Assets |
0
|
4
|
4
|
5
|
4
|
|
| Total Current Assets |
1
|
140
|
199
|
366
|
494
|
|
| PP&E Net |
0
|
0
|
2
|
2
|
2
|
|
| PP&E Gross |
0
|
0
|
2
|
2
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
121
|
0
|
0
|
0
|
1
|
|
| Total Assets |
122
N/A
|
140
+15%
|
200
+43%
|
368
+84%
|
497
+35%
|
|
| Liabilities | ||||||
| Accounts Payable |
0
|
3
|
16
|
13
|
8
|
|
| Accrued Liabilities |
1
|
7
|
6
|
9
|
15
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
5
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
1
|
15
|
23
|
21
|
23
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
28
|
|
| Other Liabilities |
4
|
0
|
1
|
1
|
2
|
|
| Total Liabilities |
5
N/A
|
16
+225%
|
24
+51%
|
23
-3%
|
53
+130%
|
|
| Equity | ||||||
| Common Stock |
112
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
1
|
185
|
112
|
189
|
298
|
|
| Additional Paid In Capital |
6
|
310
|
289
|
534
|
741
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
117
N/A
|
125
+6%
|
177
+42%
|
345
+95%
|
444
+29%
|
|
| Total Liabilities & Equity |
122
N/A
|
140
+15%
|
200
+43%
|
368
+84%
|
497
+35%
|
|
| Shares Outstanding | ||||||
| Common Shares Outstanding |
4
|
4
|
17
|
24
|
30
|
|
Switch to:
Switch to:
See Also
Discover More
